Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head-to-head trials.

Risks include respiratory failure, sepsis, and significantly higher health care utilization and costs. (HealthDay News) — Patients undergoing major surgery who experience alcohol withdrawal ...

Adults engaged in risky drinking should be provided brief behavioral counseling interventions to reduce use.

GLP-1RA use was associate with lower risks for cardiovascular events among patients with monoclonal gammopathy of undetermined significance and type 2 diabetes.

The new proposal argues that Congress didn't give the EPA permission in the Clean Air Act to regulate these emissions and that the agency essentially overstepped its power.

Among patients with NMIBC, BCG treatment may be less effective for patients with a history of UTUC, suggesting they are at greater risk for progression.

In a trial, a model gauging transplant rejection risk using donor-derived cell-free DNA and other parameters safely reduced invasive biopsies. A ‘liquid biopsy’ incorporating donor-derived ...

Resources available to clinical research physicians and the expectations placed upon these individuals vary across cancer cancers, data suggest.

Investigators systematically evaluate the efficacy differences of existing treatment regimens for IgA nephropathy.

Patients with high genetic risk for hypertension who frequently added salt to their food had especially increased risk of CKD.

Black men fare worse in confirmatory testing and face lower likelihood of potential overtreatment. (HealthDay News) — Black men with newly diagnosed prostate cancer have lower odds of ...

In patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), high levels of baseline blood urea nitrogen (BUN) are a risk factor for end-stage kidney disease (ESKD) and ...